Announced
Completed
Synopsis
Hekabio, a Japanese cancer treatment company, and Alpha Tau Medical, an Israeli medical device company, established a joint venture in Japan. The purpose of the newly formed company, Alpha Tau Medical K.K., is to supply and distribute to the Japanese market a highly potent and conformal alpha radiation-based cancer treatment, the Alpha DaRT.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.